Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study

This publication has 26 references indexed in Scilit:

• International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
  The Lancet Oncology, 2014
• Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120)
  Blood, 2014
• Progression in Smoldering Myeloma Is Independently Determined by the Chromosomal Abnormalities del(17p), t(4;14), Gain 1q, Hyperdiploidy, and Tumor Load
  Journal of Clinical Oncology, 2013
• Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma
  Leukemia, 2013
• Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant
  Blood, 2012
• Long-Term Biological Variation of Serum Protein Electrophoresis M-Spike, Urine M-Spike, and Monoclonal Serum Free Light Chain Quantification: Implications for Monitoring Monoclonal Gammopathies
  Clinical Chemistry, 2011
• Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
  Leukemia, 2010
• Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells
  British Journal of Haematology, 2009
• Prevalence of Monoclonal Gammopathy of Undetermined Significance
  New England Journal of Medicine, 2006
• A new prognostic system for multiple myeloma based on easily available parameters
  British Journal of Haematology, 1989